Filing Details
- Accession Number:
- 0001181431-10-033915
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-18 13:00:00
- Reporting Period:
- 2010-06-16
- Filing Date:
- 2010-06-18
- Accepted Time:
- 2010-06-18 16:10:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1459450 | Myriad Pharmaceuticals Inc. | MYRX | Pharmaceutical Preparations (2834) | 263996918 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1465779 | Andrew Gibbs | C/O Myriad Pharmaceuticals, Inc. 305 Chipeta Way Salt Lake City UT 84108 | Vice President, Legal | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-06-16 | 1,153 | $3.78 | 7,847 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2010, and was made to fund certain out-of-pocket tax withholding liabilities associated with the vesting of restricted stock units granted on July 1, 2009.